Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsA systematic review and meta-analysis: Does hepatitis C virus infection predispose to the development of chronic kidney disease ?Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Kidney Disease and HIV Infection.HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective.Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adultsRisk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAARTPrevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern PolandHepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis.Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.Update on HIV/HCV coinfection.Risk of coronary heart disease in patients with HIV infection.Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.Association between hepatitis C virus and chronic kidney disease: heterogeneity begets heterogeneity.Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis.Chronic kidney disease in Australian HIV-infected patients: analysis of the Australian HIV Observational Database.Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.Diagnostic challenges of kidney diseases in HIV-infected patients.Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.
P2860
Q26740117-CC8B2658-1055-4FAF-BAF8-73E9B390A8D2Q28072757-CB666BBE-9E9E-47E8-9AEC-D9A34C06B70FQ28533843-5F2C8D38-9B66-4B09-92AA-3C7DAFFDE493Q30234837-2CA22B70-5699-4835-8AA6-6ED1685DBD08Q34260569-73E6F2B9-BC27-4406-AF12-69A6F7647186Q34387456-78D6EE09-94A9-47B8-8D01-03FC39DE5826Q35645143-BE80EAB2-4F06-4429-BDFE-1BA5CDA225BAQ35964789-322DE60C-5D0B-401E-B270-5CCC190DCF6FQ36334834-1308B094-9150-46C2-A2CC-C28C42CB57F4Q36414780-FB3F8353-4E53-41CE-85E6-C474ACE165C9Q36522654-B4618922-97D5-4F28-8760-5A7325BEEF51Q36723349-ECDB6810-EAD6-4F2A-B312-722C21186994Q36903905-489DF89E-FF5A-4D9F-B26A-615607EAC2EAQ37187535-06D36D4C-1E4E-4F48-BAE1-24137587C749Q37686155-3D77E1AA-655D-4624-8BF0-D3B97F4CFF13Q38119893-4CEF4FD1-A0A5-420A-850D-8CD142D86F78Q38261508-5DB67876-79E0-4772-A243-AF931AD0487CQ38566131-B30ECF8D-346F-4FC7-AE8D-ED3FEC5D7786Q38625369-91A607CF-B2D9-4E2E-B7D3-D48011CB7A37Q38654795-EAE4E97A-C8C8-4CC6-ABA6-26B863D7F22FQ38681101-EBA5483D-417D-42C1-B587-406DE9E3F1E2Q38859678-C1CDC0A8-63FA-4584-B098-E855773B6078Q38946641-5D9E89B6-0C3D-422B-B1FB-B6F15BC3FAC7Q39097668-3DA02B1D-887C-4DCF-AEFB-6452791ED8FBQ39171447-A9DB0EE8-547B-495A-A424-2FA1EE532E52Q39644772-D4A40D48-24E1-4266-9009-56EA89E83C2DQ40043487-307F11E6-BBF9-464A-AFE7-E4793F829282Q40051440-4B03D4BA-9AAB-4B96-8C33-F9E40216106BQ47549008-9676B1D0-70F4-4687-913A-AA39A483241CQ50262252-1F41CB86-D37F-420F-AFAD-5FB46879AB3A
P2860
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@en
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@nl
type
label
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@en
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@nl
prefLabel
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@en
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@nl
P2093
P50
P1433
P1476
Hepatitis C virus viremia incr ...... ease in HIV-infected patients.
@en
P2093
EuroSIDA in EuroCoord
Helen Sambatakou
Lars Peters
Peter Reiss
P304
P356
10.1097/QAD.0B013E3283574E71
P407
P577
2012-09-01T00:00:00Z